[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Intravenous-to-Subcutaneous Drugs Sales Market Report 2021

August 2016 | 105 pages | ID: GB8698C12FAEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Intravenous-to-Subcutaneous Drugs

Revenue, means the sales value of Intravenous-to-Subcutaneous Drugs


This report studies sales (consumption) of Intravenous-to-Subcutaneous Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Amgen
  • AstraZeneca
  • Baxter
  • Britannia
  • Capricor
  • CSL Behring
  • GlaxoSmithKline
  • Grifols
  • Ferring
  • Janssen
  • NeuroDerm
  • Octapharma
  • Roche
  • Rhythm Metabolic
  • scPharmceuticals
  • SteadyMed
  • Takeda
  • United Therapeutics
  • UCB
  • US Worldmeds
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Intravenous-to-Subcutaneous Drugs in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Antibiotics
  • Antibodies
  • Anticoagulants
  • Antiemetics
  • Blood Factors
  • Diuretics
  • Hormones
  • Plasma-derived Immune Inhibitors
  • Recombinant Immunotherapeutics
  • Vasodilators
Split by applications, this report focuses on sales, market share and growth rate of Intravenous-to-Subcutaneous Drugs in each application, can be divided into
  • Medical care
  • Hospital
  • Application 3
Global Intravenous-to-Subcutaneous Drugs Sales Market Report 2021

1 INTRAVENOUS-TO-SUBCUTANEOUS DRUGS OVERVIEW

1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drugs
1.2 Classification of Intravenous-to-Subcutaneous Drugs
  1.2.1 Antibiotics
  1.2.2 Antibodies
  1.2.3 Anticoagulants
  1.2.4 Antiemetics
  1.2.5 Blood Factors
  1.2.6 Diuretics
  1.2.7 Hormones
  1.2.8 Plasma-derived Immune Inhibitors
  1.2.9 Recombinant Immunotherapeutics
  1.2.10 Vasodilators
1.3 Applications of Intravenous-to-Subcutaneous Drugs
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Intravenous-to-Subcutaneous Drugs Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drugs (2011-2021)
  1.5.1 Global Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  1.5.2 Global Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  1.5.3 Global Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Intravenous-to-Subcutaneous Drugs Market Competition by Manufacturers
  2.1.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Intravenous-to-Subcutaneous Drugs (Volume and Value) by Type
  2.2.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type (2011-2021)
  2.2.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Type (2011-2021)
2.3 Global Intravenous-to-Subcutaneous Drugs (Volume and Value) by Regions
  2.3.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Regions (2011-2021)
2.4 Global Intravenous-to-Subcutaneous Drugs (Volume) by Application

3 NORTH AMERICA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

3.1 North America Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  3.1.1 North America Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  3.1.2 North America Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  3.1.3 North America Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
3.2 North America Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
3.3 North America Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
3.4 North America Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

4 CHINA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

4.1 China Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  4.1.1 China Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  4.1.2 China Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  4.1.3 China Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
4.2 China Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
4.3 China Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
4.4 China Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

5 EUROPE INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

5.1 Europe Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  5.1.1 Europe Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  5.1.2 Europe Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
5.2 Europe Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
5.3 Europe Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
5.4 Europe Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

6 JAPAN INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

6.1 Japan Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  6.1.1 Japan Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  6.1.2 Japan Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
6.2 Japan Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
6.3 Japan Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
6.4 Japan Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

7 SOUTHEAST ASIA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  7.1.1 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
7.2 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
7.4 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

8 INDIA INTRAVENOUS-TO-SUBCUTANEOUS DRUGS (VOLUME, VALUE AND SALES PRICE

8.1 India Intravenous-to-Subcutaneous Drugs Sales and Value (2011-2021)
  8.1.1 India Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  8.1.2 India Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
  8.1.3 India Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
8.2 India Intravenous-to-Subcutaneous Drugs Sales and Market Share by Manufacturers
8.3 India Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type
8.4 India Intravenous-to-Subcutaneous Drugs Sales and Market Share by Applications

9 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS MANUFACTURERS ANALYSIS

9.1 Amgen
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.1.2.1 Antibiotics
    9.1.2.2 Antibodies
  9.1.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.2.2.1 Antibiotics
    9.2.2.2 Antibodies
  9.2.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Baxter
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.3.2.1 Antibiotics
    9.3.2.2 Antibodies
  9.3.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Britannia
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.4.2.1 Antibiotics
    9.4.2.2 Antibodies
  9.4.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Capricor
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.5.2.1 Antibiotics
    9.5.2.2 Antibodies
  9.5.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.6 CSL Behring
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.6.2.1 Antibiotics
    9.6.2.2 Antibodies
  9.6.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2016)
9.7 GlaxoSmithKline
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Grifols
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Ferring
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Janssen
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Intravenous-to-Subcutaneous Drugs Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Company One (2015 and 2021)
9.11 NeuroDerm
9.12 Octapharma
9.13 Roche
9.14 Rhythm Metabolic
9.15 scPharmceuticals
9.16 SteadyMed
9.17 Takeda
9.18 United Therapeutics
9.19 UCB
9.20 US Worldmeds

10 INTRAVENOUS-TO-SUBCUTANEOUS DRUGS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Intravenous-to-Subcutaneous Drugs Technology Analysis
10.2 Intravenous-to-Subcutaneous Drugs Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Intravenous-to-Subcutaneous Drugs
Table Classification of Intravenous-to-Subcutaneous Drugs
Figure Global Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type in 2015
Figure Antibiotics Picture
Figure Antibodies Picture
Figure Anticoagulants Picture
Figure Antiemetics Picture
Figure Blood Factors Picture
Figure Diuretics Picture
Figure Hormones Picture
Figure Plasma-derived Immune Inhibitors Picture
Figure Recombinant Immunotherapeutics Picture
Figure Vasodilators Picture
Table Applications of Intravenous-to-Subcutaneous Drugs
Figure Global Sales Market Share of Intravenous-to-Subcutaneous Drugs by Applications in 2015
Figure Medical care Examples
Figure Hospital Examples
Figure North America Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure China Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure India Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales of Key Manufacturers (2015 and 2016)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Figure 2016 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Table Global Intravenous-to-Subcutaneous Drugs Revenue by Manufacturers (2015 and 2016)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table 2016 Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drugs by Type (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Revenue Growth Rate by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Regions (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Regions (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Regions (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Regions (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue and Market Share by Regions (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drugs by Regions (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Revenue Growth Rate by Regions (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Application (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Application (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Application (2011-2021)
Figure North America Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure North America Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure North America Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table North America Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table North America Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table North America Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table North America Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table North America Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table North America Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Figure Europe Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure Europe Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table Europe Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Figure China Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure China Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure China Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table China Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Figure Japan Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure Japan Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table Japan Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Figure India Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure India Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure India Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table India Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Sales Price Trend (2011-2021)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Sales by Type (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Market Share by Type (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Sales by Applications (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Market Share by Applications (2015 and 2016)
Table Amgen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of US Worldmeds (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories